{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:09:01Z","timestamp":1788754141492,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4146-5","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T10:26:48Z","timestamp":1560508008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Invasive meningococcal disease in patients with complement deficiencies: a case series (2008\u20132017)"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-2476","authenticated-orcid":false,"given":"Shamez N.","family":"Ladhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lucidarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydel","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Willerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiswarya","family":"Lekshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,14]]},"reference":[{"key":"4146_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","volume":"10","author":"H Christensen","year":"2010","unstructured":"Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:853\u201361.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"4146_CR2","doi-asserted-by":"publisher","first-page":"B64","DOI":"10.1016\/j.vaccine.2009.04.061","volume":"27","author":"DA Caugant","year":"2009","unstructured":"Caugant DA, Maiden MC. Meningococcal carriage and disease--population biology and evolution. Vaccine. 2009;27(Suppl 2):B64\u201370.","journal-title":"Vaccine"},{"key":"4146_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/ng.640","volume":"42","author":"S Davila","year":"2010","unstructured":"Davila S, Wright VJ, Khor CC, Sim KS, Binder A, Breunis WB, et al. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet. 2010;42:772\u20136.","journal-title":"Nat Genet"},{"key":"4146_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4161\/viru.26515","volume":"5","author":"LA Lewis","year":"2014","unstructured":"Lewis LA, Ram S. Meningococcal disease and the complement system. Virulence. 2014;5:98\u2013126.","journal-title":"Virulence"},{"key":"4146_CR5","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/infdis\/jix143","volume":"215","author":"J Rosain","year":"2017","unstructured":"Rosain J, Hong E, Fieschi C, Martins PV, El Sissy C, Deghmane AE, et al. Strains responsible for invasive meningococcal disease in patients with terminal complement pathway deficiencies. J Infect Dis. 2017;215:1331\u20138.","journal-title":"J Infect Dis"},{"key":"4146_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02918259","volume":"12","author":"J Figueroa","year":"1993","unstructured":"Figueroa J, Andreoni J, Densen P. Complement deficiency states and meningococcal disease. Immunol Res. 1993;12:295\u2013311.","journal-title":"Immunol Res"},{"key":"4146_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Soci\u00e9 G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355:1233\u201343.","journal-title":"N Engl J Med"},{"key":"4146_CR8","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368:2169\u201381.","journal-title":"N Engl J Med"},{"key":"4146_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.clim.2015.08.009","volume":"161","author":"ES Reis","year":"2015","unstructured":"Reis ES, Mastellos DC, Yancopoulou D, Risitano AM, Ricklin D, Lambris JD. Applying complement therapeutics to rare diseases. Clin Immunol. 2015;161:225\u201340.","journal-title":"Clin Immunol"},{"key":"4146_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/MOP.0b013e32835df4a3","volume":"25","author":"CM Nester","year":"2013","unstructured":"Nester CM, Brophy PD. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases. Curr Opin Pediatr. 2013;25:225\u201331.","journal-title":"Curr Opin Pediatr"},{"key":"4146_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000368592","volume":"128","author":"AS Bomback","year":"2014","unstructured":"Bomback AS. Eculizumab in the treatment of membranoproliferative glomerulonephritis. Nephron Clin Pract. 2014;128:270\u20136.","journal-title":"Nephron Clin Pract"},{"key":"4146_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","volume":"17","author":"S Misawa","year":"2018","unstructured":"Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, et al. Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol. 2018;17:519\u201329.","journal-title":"Lancet Neurol"},{"key":"4146_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/13543784.2018.1443077","volume":"27","author":"F Paul","year":"2018","unstructured":"Paul F, Murphy O, Pardo S, Levy M. Investigational drugs in development to prevent neuromyelitis optica relapses. Expert Opin Investig Drugs. 2018;27:265\u201371.","journal-title":"Expert Opin Investig Drugs"},{"key":"4146_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","volume":"55","author":"SJ Gray","year":"2006","unstructured":"Gray SJ, Trotter CL, Ramsay ME, Guiver M, Fox AJ, Borrow R, et al. The epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: the contribution and experiences of the meningococcal reference unit. J Med Microbiol. 2006;55:887\u201396.","journal-title":"J Med Microbiol"},{"issue":"44","key":"4146_CR15","doi-asserted-by":"publisher","first-page":"20949","DOI":"10.2807\/1560-7917.ES2014.19.44.20949","volume":"19","author":"C Chatt","year":"2014","unstructured":"Chatt C, Gajraj R, Hawker J, Neal K, Tahir M, Lawrence M, et al. Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping, England, 2013. Euro Surveill. 2014;19(44). \n                    https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES2014.19.44.20949\n                    \n                  .","journal-title":"Eurosurveillance"},{"key":"4146_CR16","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/S1473-3099(15)00267-4","volume":"15","author":"DM Hill","year":"2015","unstructured":"Hill DM, Lucidarme J, Gray SJ, Newbold LS, Ure R, Brehony C, et al. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study. Lancet Infect Dis. 2015;15:1420\u20138.","journal-title":"Lancet Infect Dis"},{"key":"4146_CR17","doi-asserted-by":"crossref","unstructured":"Parikh SR, Lucidarme J, Bingham C, Warwicker P, Goodship T, Ramsay ME, Borrow R, Ladhani SN. First report of meningococcal B vaccine failure in a young adult on long-1 term eculizumab. Pediatrics. 2017;140. \n                    https:\/\/pediatrics.aappublications.org\/content\/140\/3\/e20162452.long\n                    \n                  .","DOI":"10.1542\/peds.2016-2452"},{"key":"4146_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.molimm.2014.06.030","volume":"61","author":"AS Grumach","year":"2014","unstructured":"Grumach AS, Kirschfink M. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Molecular Immunol. 2014;61:110\u20137.","journal-title":"Molecular Immunol"},{"key":"4146_CR19","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1084\/jem.20040111","volume":"199","author":"M Dahl","year":"2004","unstructured":"Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population based study of morbidity and mortality in mannose binding lectin deficiency. J Exp Med. 2004;199:1391\u20139.","journal-title":"J Exp Med"},{"key":"4146_CR20","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.vaccine.2018.02.038","volume":"36","author":"SR Parikh","year":"2018","unstructured":"Parikh SR, Campbell H, Gray SJ, Beebeejaun K, Ribeiro S, Borrow R, Ramsay ME, Ladhani SN. Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015. Vaccine. 2018;36:3876\u201381.","journal-title":"Vaccine"},{"key":"4146_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/527401","volume":"197","author":"MC Maiden","year":"2008","unstructured":"Maiden MC, Ibarz-Pav\u00f3n AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis. 2008;197:737\u201343.","journal-title":"J Infect Dis"},{"key":"4146_CR22","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/S0140-6736(14)60842-4","volume":"384","author":"RC Read","year":"2014","unstructured":"Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet. 2014;384:2123\u201331.","journal-title":"Lancet"},{"issue":"8","key":"4146_CR23","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3201\/eid2408.180228","volume":"24","author":"Deirdre Nolfi-Donegan","year":"2018","unstructured":"Nolfi-Donegan D, Konar M, Vianzon V, MacNeil J, Cooper J, Lurie P, et al. Fatal Nongroupable Neisseria meningitidis disease in vaccinated patient receiving Eculizumab. Emerg Infect Dis. 2018;24(8). \n                    https:\/\/doi.org\/10.3201\/eid2408.180228\n                    \n                  .","journal-title":"Emerging Infectious Diseases"},{"key":"4146_CR24","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/rheumatology\/key110","volume":"57","author":"C Sj\u00f6wall","year":"2018","unstructured":"Sj\u00f6wall C, Mandl T, Skattum L, Olsson M, Mohammad AJ. Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis). Rheumatology (Oxford). 2018;57:1400\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"4146_CR25","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/ndt\/gfx369","volume":"33","author":"Neetika Garg","year":"2018","unstructured":"Garg N, Zhang Y, Nicholson-Weller A, Khankin EV, Borsa NG, Meyer NC, et al. C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab. Nephrol Dial Transplant. 2018. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfx369\n                    \n                   [Epub ahead of print].","journal-title":"Nephrology Dialysis Transplantation"},{"key":"4146_CR26","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","volume":"388","author":"SR Parikh","year":"2016","unstructured":"Parikh SR, Andrews NJ, Beebeejaun K, Campbell H, Ribeiro S, Ward C, et al. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2016;388:2775\u201382.","journal-title":"Lancet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4146-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T23:07:39Z","timestamp":1592003259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4146-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4146"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4146-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,14]]},"assertion":[{"value":"23 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PHE has legal permission, provided by Regulation 3 of The Health Service (Control of Patient Information) Regulations 2002, to process patient confidential information for national surveillance of communicable diseases (). This includes PHE\u2019s responsibility to monitor the safety and effectiveness of vaccines. Individual patient consent is, therefore, not required by PHE from IMD cases.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AL, AW, JL, LW, RB, SAC, SG, SL, SP and XB perform contract research on behalf of Public Health England for GSK, Pfizer and Sanofi Pasteur. All other authors: no conflict.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"522"}}